🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Children, adolescents, and young adults (CAYA) with relapsed/refractory (R/...
Status
Recruiting
Location
New York Medical College
Start Date
2025-08-07
Trial ID
NCT07013565
Treatments Being Tested
A Randomized Phase IIb Study, Evaluating Efficacy of Salvage Therapy with B...
Status
Recruiting
Location
Institut Català D'Oncologia - Hospital Germans Trias I Pujol
Start Date
2020-06-01
Trial ID
NCT04378647
The addition of targeted immunotherapy will be safe and well tolerated and ...
Status
Recruiting
Location
University of Alabama
Start Date
2022-02-01
Trial ID
NCT05253495
Treatments Being Tested
It has been recently reported that EATL type 1, but not refractory coeliac ...
Status
Completed
Location
Hopital Necker - Enfants malades
Start Date
2018-02-07
Trial ID
NCT03217643
Treatments Being Tested
Peripheral T-cell lymphoma (PTCL) encompasses a broad range of post-thymic ...
Status
Recruiting
Location
Chu D'Amiens - Hopital Sud
Start Date
2022-08-01
Trial ID
NCT05444712
Treatments Being Tested
This phase II trial studies the side effects and how well brentuximab vedot...
Status
Active Not Recruiting
Location
City of Hope Comprehensive Cancer Center
Start Date
2017-05-25
Trial ID
NCT03113500
This phase II trial evaluates how well AVD (doxorubicin, vinblastine, dacar...
Status
Active Not Recruiting
Location
City of Hope Comprehensive Cancer Center
Start Date
2017-10-13
Trial ID
NCT03233347
Treatments Being Tested
Phase I trial aimed to determine the Maximum Tolerable Dose of the BV in co...
Status
Completed
Location
Hospital Son Espases
Start Date
2014-11-11
Trial ID
NCT02243436
Treatments Being Tested
Adult T-cell leukemia/lymphoma (ATLL) is a rare form of cancer found mostly...
Status
Completed
Location
South Broward/Memorial Healthcare System
Start Date
2018-10-11
Trial ID
NCT03264131
Treatments Being Tested